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Abstract 
Background: Severe preeclampsia is still a major problem in the world, because of  
the increased of maternal mortality due to cardiovascular diseases (CVD). 
Detection of CRP (high C-reactive protein) using the high sensitivity method is a 
usefull prediction for CVD among non preeclamptic patients. This study aimed to 
investigate the total of CRP levels in maternal serum of severe preeclampsia and 
normotensive.  
Objective: To determine the differences levels of CRP among severe preeclampsia 
and normal pregnancy patients using hs CRP method 
Method: A descriptive cross sectional study was conducted to 26 severe 
preeclampsia (53%) and 23 normal pregnancy (46,9%) subjects / patients in 
puerperial period (2-6 weeks) . Exclusion criteria were puerperal infection, chronic 
hypertension, metabolic syndrome, caesarean section delivery. All subjects were 
examined the levels of CRP using hs CRP method. maternal serum. 
Result: The mean levels of CRP in severe preeclampsia was 4.73 + 3.57 while in 
normotensive 2.42 + 4.14 (p <0.05). Severe preeclampsia group hada risk of 
increase CRP maternal serum 2.5 times compared to the normotensive group. 
Conclusion: Level of CRP in patients with preeclampsia post partum is higher 
than patients with normal pregnancies.  
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INTRODUCTION 
 Maternal deaths in the world are mostly caused 
by bleeding (27%), infection (11%), pre-eclampsia 
and eclampsia(14%).1 According  to the data from 
Indonesian Demographic Health Survey (IDHS), 
maternal death were caused by 359 to 100,000 of live 
births and severe preeclampsia contributes of 
24%.Maternal mortality of severe preeclampsia in the 
puerperal period is likely to be greater because of 
cardiovascular, cerebrovascular, renal, and 
thromboembolism complications.2 
 Cardiologic department commonly used hsCRP 
method to detect CRP as aprediction biomarker of 
acute coronary syndrome (ACS). 
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ACS risk is about 2.8 times higher in severe 
preeclampsia compared with normotensive 
pregnancy.3 These biomarkers can be detected early, 
so patients can be educated to lifestyle modification 
and cardiologists can do early prophylactic treatment 
of ACS.4 Recent research showed a link between 
severe preeclampsia and levels of maternal CRP 
serum using the hsCRP method. CRP will still 
increase during less than 2 weeks of postnatal period 
due to inflammatory process. This marker in severe 
preeclampsia remained high but still unclear whether 
CRP maternal serum level in the postnatal period of 2 
to  6 weeks. One of advantage knowing CRP earlier at 
postnatal period, it will easier to educate patient for 
lifestyle modification, same as educate for 
contraception. So the purpose of this study was to 
determine the level of maternal serum CRP levels in 
puerperal period of severe preeclampsia compared 
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with normotensive subjects / patients using the hs 
CRP method in the postnatal period at 2 to 6 weeks. 
 
MATERIALS AND METHODS 
 The method of this study was descriptive research 
using cross sectional design. The inclusion criteria 
were subjects in puerperal period with a history of 
severe preeclampsia and normotensive. Exclusion 
criteria were puerperal infection, metabolic syndrome 
andcaesarean section delivery. Puerperal period was 
between 2 – 6 weeks after delivery. Severe 
preeclampsia were diagnosed using criteria at least 
one of the following symptoms blood pressure ≥ 
160/110 mmHg, proteinuria ≥ 5 g/24 hours or ≥ +2 
dipstick and one organ involvement: 
thrombocytopenia (<100.000/ul), hemolysis 
microangiopati, increasing SGOT and SGPT, the 
persistence of headache, eyesight scotoma, fetus: fetal 
growth retardation, oligohydramnios, pulmonary 
edema or congestive heart failure, oliguria (≤ 500 
ml/24 hours) and serum creatinine ≥ 1,2 mg/dL.  
 
Maternal serum were taken from venous blood 
samples about 5cc fromthe median cubital vein. Those 
serum were taken from severe preeclampsia when 
blood pressure  140 / 90. CRP serum level were 
measured using hsCRP method with LTIA (Latex 
Turbidimetric Immunoassay). Other demographic and 
clinical variables were included such as age, gravidity, 
parity, abortion, gestational age when delivery, body 
mass index (BMI), birthweight, education, occupation 
and methods of vaginal deliveryto know the 
differences between two groups.  
 
RESULTS 
  Table 1 showed that characteristics of subjects 
were almost homogen. The difference among two 
groups was method of vaginal delivery, because 
mostly vacuum extraction has done for accelerate 
delivery of severe preeclampsia. Severe preeclampsia 
delivered with vacuum extraction at 68%of women 
and the majority of normotensive woman delivered 
baby spontaneously (62,5%).  
 
 
Table 1. Characteristics of subjects 
 Normotensive (n=23) Severe preeclampsia (n=26) 
p  
Mean±SD 
Median(min-
maks) N(%) 
Mean±SD 
Median(min-maks) N(%) 
Age (year) 28±5 
27(21-41) 
 
31±7 
31(1-41) 
 
0,06a 
Gravida 2±1 
2(1-6) 
 
3±1 
3(1-4) 
 
0,05a 
Parity 2±1 
2(0-4) 
 
2±1 
2(0-4) 
 
0,28a 
Abortion 0±1 
0(0-4) 
 
0±1 
2(0-4) 
 
0,22a 
Gestation 
(week) 
38±2 
39(34-41) 
 
38±2 
39(32-40) 
 
0,44a 
BMI 25,12±5,18  27.04±5,64  0,23
b 
Birth weight 
(gram) 
3089±764 
3100(1900-5200) 
 
2688±553 
2800(1300-3500) 
 
0,06a 
Education Elementary  6(26,1)  10(40,0) 0,98
c 
 Junior  High 
School 
 5(21,7)  5(20,0) 
 
 High School 
/ Vocational 
School 
 9(39,1)  7(28,0) 
 
 First Degree 
(S1) 
 3(13,0)  3(12,0) 
 
Occupation IRT  17(73,9)  21(84,0) 1,00
c 
 Private  2(8,7)  1(4,0)  
 Trader  2(8,7)  2(8,0)  
 Teacher  0(0,0)  1(4,0)  
 SPG  1(4,3)  0(0,0)  
 Doctor  1(4,3)  0(0,0)  
Method of Spontaneous  15(65,2)  8(32,0) 0,02
d 
delivery VE  8(34,8)  17(68,0) - 
a. Mann Whitney Test 
b. Independent TTest 
c. Kolmogorov Smirnov Test 
d. X2Test 
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Table 2. The maternal serum of hsCRP of severe 
preeclampsia and normotensive. 
Group 
Normotensive 
(n=23) 
Severe 
preeclampsia 
(n=26) 
p 
hsCRP (mg/L) 
mean + SD 
Relative risk(RR) 
2,42±4,14 
 
2.55 
4,73±3,57 
 
 
0,0001a 
 
0.03 
    
Table 2 showed the average levels of hsCRP in 
normotensive women (2.42 mg/L ) was lower than 
preeclamptic group (4.73 mg/L), p value = 0.0001 
(<0.05). Severe preeclampsia increased the risk of 
hsCRP level was 2.5 times compared with 
normotensive. 
 
DISCUSSION 
 In general, CRP shows the degree of 
inflammatory activityduring early 2 weeks of 
postnatal period.7 The high inflammatory activity 
were occurred in early puerperal period (6 – 12 
firsthour). After that, the inflammatory activity were 
decrease until 2 weeks and steady state until the end 
of puerperal period.8 So, this study measured hsCRP 
at 2 – 6 weeks of puerperal period. If hsCRP > 10 
mg/L reflect high inflammatory activity or acute 
infection.9 The level of hsCRP in this study were < 10 
mg/L. It means that the inflammatory activity were 
decreased. 
 Many studies concluded that severe preeclampsia 
increased risk of cardiovascular complication related 
with chronic hypertension and metabolic syndrome 
such as dislipidemiaand insulin resistant.10 This study 
focused on woman with severe preeclampsia without 
metabolic syndrome comorbodities. BMI were similar 
between two groups.CRP in cardiology department 
were measured to predict risk of ACS in healthy 
people, before appear of significant clinical sign.CRP 
 3 - 10 mg/L was categorized as high risk of 
cardiovascular complication.7 
 In this study, patients with severe preeclampsia 
had higher maternal CRP serum level than 
normotensive patients in puerperal period. This result  
similar with other former studies.4,6, We conclude that  
CRP maternal serum detected by hsCRP method at 
puerperal period can be used as a masker for 
prediction of ACS. If patients can be aware earlier, it 
will easier to educate them with life style 
modification. 
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